Jeremy Tanner explores the relationship between various PET modalities (amyloid, tau and FDG), and cognition (episodic memory, semantic memory, language, executive function and visuospatial domains), both in early and late-onset Alzheimer's Disease. Mounting evidence of tau PET as a biomarker of clinical severity and molecular pathology across diferent ages and clinical phenotypes of AD.
